[HTML][HTML] Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms

AD Proal, MB VanElzakker - Frontiers in microbiology, 2021 - frontiersin.org
The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients …

Targeting cancers through TCR-peptide/MHC interactions

Q He, X Jiang, X Zhou, J Weng - Journal of hematology & oncology, 2019 - Springer
Adoptive T cell therapy has achieved dramatic success in a clinic, and the Food and Drug
Administration approved two chimeric antigen receptor-engineered T cell (CAR-T) therapies …

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

F Liew, C Efstathiou, S Fontanella, M Richardson… - Nature …, 2024 - nature.com
One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged
symptoms termed long coronavirus disease (COVID), yet disease phenotypes and …

Non-thermal plasma as a novel strategy for treating or preventing viral infection and associated disease

H Mohamed, G Nayak, N Rendine, B Wigdahl… - Frontiers in …, 2021 - frontiersin.org
Pathogenic viruses cause many human, animal, and plant diseases that are associated with
substantial morbidity, mortality and socio-economic impact. Although effective strategies for …

Microbes and cancer: friends or faux?

MM Azevedo, C Pina-Vaz, F Baltazar - International journal of molecular …, 2020 - mdpi.com
Cancer is one of the most aggressive and deadly diseases in the world, representing the
second leading cause of death. It is a multifactorial disease, in which genetic alterations play …

Polyploid giant cancer cells, a hallmark of oncoviruses and a new therapeutic challenge

G Herbein, Z Nehme - Frontiers in Oncology, 2020 - frontiersin.org
Tumors are renowned as intricate systems that harbor heterogeneous cancer cells with
distinctly diverse molecular signatures, sizes and genomic contents. Among those various …

The gut virome in inflammatory bowel disease pathogenesis: from metagenomics to novel therapeutic approaches

F Ungaro, L Massimino, S D'Alessio… - United European …, 2019 - journals.sagepub.com
The association of intestinal dysbiosis with the pathogenesis of inflammatory bowel disease
has been well established. Besides bacteria, microbiota comprises yeasts, archaea, protists …

TCR-like antibodies in cancer immunotherapy

Q He, Z Liu, Z Liu, Y Lai, X Zhou, J Weng - Journal of hematology & …, 2019 - Springer
Cancer immunotherapy has been regarded as the most significant scientific breakthrough of
2013, and antibody therapy is at the core of this breakthrough. Despite significant success …

Combinatorial drug therapy in cancer-New insights

K Bhatia, A Das - Life Sciences, 2020 - Elsevier
Cancer can arise due to mutations in numerous pathways present in our body and thus has
many alternatives for getting aggravated. Due to this attribute, it gets difficult to treat cancer …

[图书][B] New and future developments in microbial biotechnology and bioengineering: microbes in soil, crop and environmental sustainability

JS Singh - 2019 - books.google.com
New and Future Developments in Microbial Biotechnology and Bioengineering: Microbes in
Soil, Crop and Environmental Sustainability reviews the exploitation of microbial biodiversity …